Skip to content
10-K

Annual Report

PLIANT THERAPEUTICS, INC. PLRX

0001746473-26-000037

← back to feed
Filed
Mar 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 5, 2026 61.91M sh
Shares Diluted FY 2025 · Dec 31, 2025 61.37M sh
Shares Diluted FY 2025 · Dec 31, 2024 60.54M sh
Capex FY 2025 · Dec 31, 2025 $374K
Capex FY 2025 · Dec 31, 2024 $3.85M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$128.34M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$155.5M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $30.21M
Short Term Investments FY 2025 · Dec 31, 2025 $145.5M
Short Term Investments FY 2025 · Dec 31, 2024 $284.54M
Cash And Equivalents FY 2025 · Dec 31, 2025 $45.45M
Cash And Equivalents FY 2025 · Dec 31, 2024 $71.19M
Stockholders Equity FY 2025 · Dec 31, 2025 $181.21M
Stockholders Equity FY 2025 · Dec 31, 2024 $304.08M
Stockholders Equity FY 2025 · Dec 31, 2023 $473.58M
Current Liabilities FY 2025 · Dec 31, 2025 $16.37M
Current Liabilities FY 2025 · Dec 31, 2024 $33.22M
Total Liabilities FY 2025 · Dec 31, 2025 $44.02M
Total Liabilities FY 2025 · Dec 31, 2024 $92.87M
Current Assets FY 2025 · Dec 31, 2025 $196.45M
Current Assets FY 2025 · Dec 31, 2024 $362.26M
Total Assets FY 2025 · Dec 31, 2025 $225.23M
Total Assets FY 2025 · Dec 31, 2024 $396.95M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.43
Eps Diluted FY 2025 · Dec 31, 2024 −$3.47
Eps Basic FY 2025 · Dec 31, 2025 −$2.43
Eps Basic FY 2025 · Dec 31, 2024 −$3.47
Sga Expense FY 2025 · Dec 31, 2025 $47.22M
Sga Expense FY 2025 · Dec 31, 2024 $59.06M
Rd Expense FY 2025 · Dec 31, 2025 $109.16M
Rd Expense FY 2025 · Dec 31, 2024 $169.31M
Net Income FY 2025 · Dec 31, 2025 −$149.34M
Net Income FY 2025 · Dec 31, 2024 −$210.3M
Operating Income FY 2025 · Dec 31, 2025 −$156.37M
Operating Income FY 2025 · Dec 31, 2024 −$228.37M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $0